| NME2 antibodies | |
| This is a review about NME2 antibodies, based on 3 published articles using NME2 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited NME2 antibody. Information in this review (with links to publications) can be searched freely. |
SIGMA-ALDRICH search Sigma-Aldrich NME2 products
includes other brands or spellings
|
| ih | | Sigma NME2 antibody was tested in immunohistochemistry by Human Protein Atlas. |
SEIGAKAKU
|
| ic | | Seigakaku monoclonal antibody against nm23-H2 was used in immunocytochemistry to provide the first evidence that the tumor suppressor nm23-H2 could act on beta1 integrin-mediated cell adhesion by interacting with one of the integrin partners ICAP-1alpha. |
SEIKAGAKU CORPORATION
|
| ih | | Seikagaku Corporation monoclonal anti-nm23-H2 antibody (clone H2–206) was used in paraffin sections from human lymphoma cells and in immunohistochemistry to study the role for intracytoplasmic nm23-H1 in diagnosising diffuse large B-cell lymphoma. |
Articles Reviewed |
| 1. Henri-Noël Fournier et al. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. 2002 |
| 2. Nozomi Niitsu et al. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma. 2004 |
| 3. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|